Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPC-12759 in Dry Eye
NCT01660256Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Aug 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rebamipide in dry eye syndrome (DED), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Aug 2012; status: completed.
02
Drugs
rebamipide
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01660256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01660256.